Medasense Welcomes Holly Stewart as VP of Sales, North America
With over 30 years of experience in healthcare across the Americas, Holly Stewart has joined the Medasense team in the role of North American VP of Sales.
With over 30 years of experience in healthcare across the Americas, Holly Stewart has joined the Medasense team in the role of North American VP of Sales.
In an update on the U.S. Food and Drug Administration’s efforts in combatting harm from opioids, FDA commissioner Robert M. Califf, MD highlighted the recent marketing authorization of NOL technology
Now in the U.S! Medasense is gearing up to introduce NOL at U.S. 2023 conferences
The Israel Tech & Innovation Media site NoCamels publishes article about NOL
The chronic pain news service, Pain News Network, featured an interview given by Medasense CEO Galit Zuckerman Stark
Agency clearance paves way for commercialization in the United States of first and only authorized device to measure pain in anesthetized patients undergoing surgery
Agency clearance paves way for commercialization in the United States of first and only authorized device to measure pain in anesthetized patients undergoing surgery
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.